Net profit of Borosil Scientific declined 0.65% to Rs 7.69 crore in the quarter ended September 2024 as against Rs 7.74 crore during the previous quarter ended September 2023. Sales rose 3.19% to Rs 87.04 crore in the quarter ended September 2024 as against Rs 84.35 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales87.0484.35 3 OPM %15.3014.81 - PBDT15.0513.57 11 PBT10.8210.07 7 NP7.697.74 -1 Powered by Capital Market - Live News

Borosil Scientific will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live News

Borosil Scientific has allotted 18,020 equity shares under ESOP on 16 October 2024. With this allotment, the paid up equity share capital has increased to Rs. 8,88,80,203 divided into 8,88,80,203 equity shares of Re 1 each. Powered by Capital Market - Live News

Borosil Scientific has allotted 49,089 equity shares under ESOP on 21 August 2024. Pursuant to the aforesaid allotment of equity shares, the issued and paid up equity share capital of the Company stands increased to Rs. 8,88,45,481 divided into 8,88,45,481 equity shares of face value of Re. 1/- each.Powered by Capital Market - Live News

Net profit of Borosil Scientific rose 54.05% to Rs 6.47 crore in the quarter ended June 2024 as against Rs 4.20 crore during the previous quarter ended June 2023. Sales rose 17.17% to Rs 93.40 crore in the quarter ended June 2024 as against Rs 79.71 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales93.4079.71 17 OPM %11.737.88 - PBDT12.867.02 83 PBT8.663.65 137 NP6.474.20 54 Powered by Capital Market - Live News